Kopin Receives Second Production Order for Wearable Surgical Information Display
Kopin (NASDAQ: KOPN) has received a second production order for the CR3 wearable surgical monitor from HMDmd, Inc. The CR3 is a lightweight, ergonomic head-mounted display that provides 3-D imagery in full-HD resolution and is 4K video compatible. It's designed for use with 2-D and 3-D endoscopes and microscopes, offering surgeons a constant high-resolution video of the surgical field while maintaining visual access to the operating room.
The order follows positive feedback from surgical equipment manufacturers. The market opportunity is estimated to grow to over 750,000 HMDs worldwide, with a potential 2029 delivery opportunity of up to 150,000 units. The CR3 is expected to be particularly beneficial for microscopy, minimally invasive surgery, digital and robotic surgery, and interventional medicine.
Kopin (NASDAQ: KOPN) ha ricevuto un secondo ordine di produzione per il monitor chirurgico indossabile CR3 da HMDmd, Inc. Il CR3 è un display ergonomico leggero da indossare sulla testa che fornisce immagini tridimensionali in risoluzione full-HD ed è compatibile con video 4K. È progettato per l'uso con endoscopi e microscopi 2-D e 3-D, offrendo ai chirurghi un video ad alta risoluzione costante del campo chirurgico, mantenendo al contempo l'accesso visivo alla sala operatoria.
L'ordine segue feedback positivi da parte dei produttori di attrezzature chirurgiche. Si stima che l'opportunità di mercato crescerà fino a oltre 750.000 HMD in tutto il mondo, con una possibilità di consegna nel 2029 di fino a 150.000 unità. Si prevede che il CR3 sarà particolarmente utile per la microscopia, la chirurgia minimamente invasiva, la chirurgia digitale e robotica, e la medicina interventistica.
Kopin (NASDAQ: KOPN) ha recibido un segundo pedido de producción para el monitor quirúrgico portátil CR3 de HMDmd, Inc. El CR3 es un monitor ligero y ergonómico montado en la cabeza que proporciona imágenes en 3-D en resolución full-HD y es compatible con video 4K. Está diseñado para su uso con endoscopios y microscopios 2-D y 3-D, ofreciendo a los cirujanos un video constante de alta resolución del campo quirúrgico mientras mantiene el acceso visual a la sala de operaciones.
El pedido sigue a comentarios positivos de los fabricantes de equipos quirúrgicos. Se estima que la oportunidad de mercado crecerá a más de 750,000 HMD en todo el mundo, con una oportunidad de entrega en 2029 de hasta 150,000 unidades. Se espera que el CR3 sea particularmente beneficioso para la microscopía, la cirugía mínimamente invasiva, la cirugía digital y robótica, y la medicina intervencionista.
Kopin (NASDAQ: KOPN)은 HMDmd, Inc.로부터 CR3 웨어러블 수술 모니터에 대한 두 번째 생산 주문을 받았습니다. CR3는 가벼운 인체공학적 헤드 마운트 디스플레이로, 3D 이미지를 풀 HD 해상도로 제공하며 4K 비디오와 호환됩니다. 2D 및 3D 내시경 및 현미경과 함께 사용하도록 설계되어 있으며, 외과의사들에게 수술 분야의 고해상도 비디오를 지속적으로 제공하면서 수술실에 대한 시각적 접근을 유지합니다.
이번 주문은 외과용 장비 제조업체들로부터 긍정적인 피드백에 따른 것입니다. 시장 기회는 전 세계적으로 750,000개의 HMD 이상으로 성장할 것으로 예상되며, 2029년에는 최대 150,000대의 납품 기회가 있을 것입니다. CR3는 미세 수술, 최소 침습 수술, 디지털 및 로봇 수술, 그리고 중재의학에 특히 유익할 것으로 예상됩니다.
Kopin (NASDAQ: KOPN) a reçu une deuxième commande de production pour le moniteur chirurgical portable CR3 de HMDmd, Inc. Le CR3 est un affichage léger et ergonomique monté sur la tête qui fournit des images en 3D en résolution full-HD et est compatible avec la vidéo 4K. Il est conçu pour être utilisé avec des endoscopes et des microscopes en 2D et 3D, offrant aux chirurgiens une vidéo haute résolution constante du champ opératoire tout en maintenant un accès visuel à la salle d'opération.
La commande suit des retours positifs de la part des fabricants d'équipements chirurgicaux. L'opportunité de marché devrait croître pour dépasser 750 000 HMD dans le monde, avec un potentiel de livraison de 150 000 unités d'ici 2029. Le CR3 devrait être particulièrement bénéfique pour la microscopie, la chirurgie peu invasive, la chirurgie numérique et robotique, ainsi que la médecine interventionnelle.
Kopin (NASDAQ: KOPN) hat einen zweiten Produktionsauftrag für den tragbaren chirurgischen Monitor CR3 von HMDmd, Inc. erhalten. Der CR3 ist ein leichtes, ergonomisches Kopfdisplay, das 3D-Bilder in Full-HD-Auflösung liefert und mit 4K-Videos kompatibel ist. Er wurde für die Verwendung mit 2D- und 3D-Endoskopen und Mikroskopen entwickelt und bietet Chirurgen ein kontinuierliches hochauflösendes Video des Operationsfeldes, während der visuelle Zugang zum Operationssaal erhalten bleibt.
Die Bestellung folgt auf positives Feedback von Herstellern chirurgischer Geräte. Die Marktchance wird auf über 750.000 HMDs weltweit geschätzt, mit einer potenziellen Lieferchance von bis zu 150.000 Einheiten im Jahr 2029. Der CR3 wird voraussichtlich insbesondere für die Mikroskopie, die minimalinvasive Chirurgie, die digitale und robotergestützte Chirurgie sowie die intervenierende Medizin von Vorteil sein.
- Received second production order for CR3 wearable surgical monitor
- Positive feedback from surgical equipment manufacturers
- Large market opportunity: estimated 750,000 HMDs worldwide
- Potential 2029 delivery opportunity of up to 150,000 units
- CR3 offers advanced features: 3-D imagery, full-HD resolution, 4K video compatibility
- None.
Insights
The second production order for Kopin's CR3 wearable surgical monitor signals positive market reception and potential for accelerated adoption in the surgical equipment sector. The CR3's unique features, including 3-D imagery in full-HD resolution and 4K compatibility, address critical needs in surgical visualization. The "look-down" capability and ergonomic design could be game-changers for surgeon comfort and efficiency.
With an estimated market of
This development represents a strategic move by Kopin into the high-value medical technology market. The positive feedback from surgical equipment manufacturers suggests potential for strong partnerships and distribution channels. The CR3's compatibility with existing surgical systems could facilitate faster market penetration.
The estimated market size of 304,000 operating rooms in the U.S., Europe and Asia presents a substantial opportunity. However, investors should consider the sales cycle length in healthcare and potential regulatory hurdles. The projected 150,000 unit delivery by 2029 implies a
While this second order is promising, investors should note that Kopin hasn't disclosed the order size or financial terms. The company's ability to capitalize on this opportunity and translate it into substantial revenue growth remains to be seen. Kopin's diverse portfolio across defense, enterprise and consumer sectors provides some risk mitigation, but success in the medical market could be a significant growth driver.
Investors should monitor Kopin's gross margins and operating expenses as production scales up. The company's ability to manage costs while ramping up production will be crucial. Additionally, keep an eye on Kopin's cash position and burn rate, as expanding into new markets often requires significant investment. While the long-term potential is intriguing, short-term financial impacts may be until wider adoption is achieved.
The CR3 is a lightweight, ergonomic head-mounted display (“HMD”) that provides 3-D imagery in full-HD resolution, while also being 4K video compatible. The CR3 is configured for use with 2-D and 3-D endoscopes and microscopes and is plug-in compatible with other surgical systems.
“This second production order is a direct result of the positive feedback we received from the surgical equipment manufacturers who evaluated the CR3 HMD,” said Bill Maffucci, Kopin's Senior VP of Business Development and Strategy. “We anticipate adoption rates to accelerate as more surgeons have the opportunity to evaluate the CR3.”
The CR3 enables surgeons to maintain a constant high-resolution video of the surgical field while also being able to maintain full visual access to the operating room via a unique “look-down” capability. The CR3 also minimizes weight on the surgeon’s head and is extremely well-balanced to minimize head and neck strain.
"In terms of functionality, the CR3 is a massive leap forward,” said John Lyon, CEO of HMDmd. “We see the HMD being particularly beneficial for surgical use-cases in microscopy, minimally invasive surgery, digital and robotic surgery and interventional medicine. The feedback from surgeons and surgical equipment manufacturers has been very positive, and we are expanding marketing and business development activities with prospective distribution partners.”
With over 189,000 operating rooms in
About Kopin
Kopin Corporation is a leading developer and provider of innovative display, and optical technologies sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Kopin’s portfolio includes microdisplays, display modules, eyepiece assemblies, image projection modules, and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (µLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com.
Kopin is a trademark of Kopin Corporation.
About HMDmd, Inc.
HMDmd, based in
Forward-Looking Statements
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. These forward-looking statements include our expectation adoption rates of the CR3 to accelerate as more surgeons have the opportunity to evaluate the CR3. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 30, 2023, or as updated from time to time our Securities and Exchange Commission filings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240912484964/en/
Kopin Corporation
Bill Maffucci, 508-870-5959
SVP of Business Development and Strategy,
bmaffucci@kopin.com
Richard Sneider, 508-870-5959
Treasurer and Chief Financial Officer
Richard_Sneider@kopin.com
or
MZ Contact:
Brian M. Prenoveau, CFA, 561 489 5315
MZ Group – MZ North America
KOPIN@mzgroup.us
HMDmd Inc
John
CEO
John.lyon@hmdms.com
Source: Kopin Corporation
FAQ
What is the CR3 wearable surgical monitor produced by Kopin (KOPN)?
How large is the market opportunity for Kopin's (KOPN) CR3 wearable surgical monitor?
What are the main applications for Kopin's (KOPN) CR3 wearable surgical monitor?
Has Kopin (KOPN) received any feedback on their CR3 wearable surgical monitor?
